Latest News

Medicare is imposing strict new restrictions that advocates are worried could affect retirees.

Bitcoin may not turn things around by March, but that shouldn't matter if you're a long-term buy-and-hold investor.

The S&P 500 trades at its most expensive valuation in 25 years, and the economy is showing signs of weakness.

The Oracle of Omaha is unwavering when it comes to value -- even with his favorite stock to buy.

Coinbase's diversification away from crypto should make it less susceptible to the ebbs and flows of the crypto market.

REITs come in all shapes and sizes, but the healthcare REIT you should look at is Welltower.

Whether you're happy or not will likely depend on your situation.

The total stablecoin market capitalization reached a record $313 billion, rising 1.14% over the past week, according to DefiLlama data.

Oil stocks are taking a wait-and-see approach to the war.

The founder cited remarks from a former FDA official and an NIH Director supporting mechanism-based review to speed patient access to therapies like Anktiva.

The CEO said Sellas is pursuing a “security force” immunotherapy strategy that trains immune cells to recognize cancer even as tumors evolve.

Agilent expects the deal to boost revenue growth and margins in the first year, with the transaction projected to add to earnings per share about 12 months after closing.

This top retail stock underperformed the S&P 500 in the past five and 10 years.

Data from Stocktwits showed that retail sentiment on SPY and QQQ remains ‘bearish.’

OpenAI is tweaking ChatGPT’s e-commerce flow so that checkouts occur within partner apps plugged into ChatGPT, rather than directly inside the chatbot, as previously planned.